The first news was a footnote, a rumor in the flood of chaos. A midwife at a Zarqa clinic, north of Amman, made an anonymous complaint to an embryonic, underground network tracking the "Touched." One of the first patients to be treated with Dawud's cure for hepatitis had given birth.
The baby was fine, healthy, but its immune markers were… off the charts.
The midwife described it as "like it was born with the defenses of a ten-year-old." The story was promoted, then buried under more urgent news of riots and fatwas.
Another arrived. Another mother, from another camp, was cured of drug-resistant TB. Her baby did not cry. It cooed, a creeping sense of unease, and its eyes, the midwife swore, seemed to track movement weeks earlier than any baby should. Its ears are so sensitive that it wou
